Cognitive Interview-Based Validation of the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events in Adolescents with Cancer.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of pain and symptom management"
DOI: 10.1016/j.jpainsymman.2016.11.006
Abstract: CONTEXT The National Cancer Institute created the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) to allow direct input on symptomatic adverse events (AEs) from adult patients in oncology trials. OBJECTIVES… read more here.
Keywords: version; adverse events; cancer; pro ctcae ... See more keywords
Validity and Reliability of the Pediatric Patient-Reported Outcomes - Common Terminology Criteria for Adverse Events.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of the National Cancer Institute"
DOI: 10.1093/jnci/djaa016
Abstract: BACKGROUND Patient-reported outcome (PRO) measurements linked to Common Terminology Criteria for Adverse Events (CTCAE) grading may improve symptom adverse event (AE) reporting in pediatric oncology trials. We evaluated construct validity, responsiveness, and test-retest reliability of… read more here.
Keywords: ped pro; pro ctcae; oncology; patient reported ... See more keywords
Translation Into Simplified Chinese and Cultural Validation of the Pediatric Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Using Cognitive Interviewing
Sign Up to like & getrecommendations! Published in 2022 at "Cancer Nursing"
DOI: 10.1097/ncc.0000000000001090
Abstract: Background The original English Pediatric Patient-Reported Outcome version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) captures symptomatic adverse events (AEs) in cancer clinical trials from the perspective of pediatric patients. A Chinese version… read more here.
Keywords: oncology; pro ctcae; patient reported; version ... See more keywords
Validity and reliability of the simplified Chinese patient-reported outcomes version of the common terminology criteria for adverse events
Sign Up to like & getrecommendations! Published in 2021 at "BMC Cancer"
DOI: 10.1186/s12885-021-08610-0
Abstract: Background The psychometric properties of the simplified Chinese version of the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) have not been assessed. Therefore, we aimed to assess its validity, reliability,… read more here.
Keywords: version; validity; simplified chinese; reliability ... See more keywords
Content validation of an electronic remote toxicity management system in adult patients undergoing cancer treatment: a prospective longitudinal study on the QuestOnco application
Sign Up to like & getrecommendations! Published in 2024 at "BMC Cancer"
DOI: 10.1186/s12885-024-13312-4
Abstract: Cancer-treatment toxicity is common and symptoms must be identified quickly and accurately. Since symptom reporting during consultations is hampered by time constraints and patient/oncologist biases, patient-reported outcome-measure (PROM) questionnaires are useful. A strong shift to… read more here.
Keywords: cancer; content; pro ctcae; application ... See more keywords
Evaluation of the patient-reported outcomes common terminology criteria for adverse events (PRO-CTCAE) with abiraterone acetate plus prednisone (AAP), degarelix (D), or the combination in men with biochemically recurrent prostate cancer (BCRPC).
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2019.37.15_suppl.5080
Abstract: 5080 Background: Patient-reported symptoms using the PRO-CTCAE provide insights into the patient experience with care. Earlier use of AAP (an androgen biosynthesis inhibitor plus prednisone) with androgen deprivation therapy in castration sensitive disease may lead… read more here.
Keywords: pro ctcae; plus prednisone; aap; patient reported ... See more keywords
The PRO-CTCAE in oncology clinical trials: Insights from a targeted literature review.
Sign Up to like & getrecommendations! Published in 2025 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2025.43.16_suppl.e23193
Abstract: e23193 Background: The Patient-Reported Outcomes Common Terminology Criteria for Adverse Events (PRO-CTCAE) is a tool used to collect information on symptomatic adverse events (AEs) directly from patients in oncology clinical trials. It has been designated… read more here.
Keywords: oncology; item selection; pro ctcae; clinical trials ... See more keywords
Linguistic Validation of the US National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events in Korean
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Global Oncology"
DOI: 10.1200/jgo.18.00193
Abstract: PURPOSE The aim of this study was to translate and linguistically validate a Korean-language version of the US National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). METHODS All… read more here.
Keywords: pro ctcae; institute patient; cancer institute; cancer ... See more keywords
A study demonstrating users’ preference for the adapted-REQUITE patient-reported outcome questionnaire over PRO-CTCAE® in patients with lung cancer
Sign Up to like & getrecommendations! Published in 2024 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2024.1328871
Abstract: Introduction The use of patient-reported outcomes (PROs) has been shown to enhance the accuracy of symptom collection and improve overall survival and quality of life. This is the first study comparing concordance and patient preference… read more here.
Keywords: cancer; correlation; pro ctcae; questionnaire ... See more keywords